Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2015-07-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00432-014-1888-8PMID 25446815PMCID PMC11823669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma

  2014cited by this paper
• Monocarboxylate Transporter 4 Facilitates Cell Proliferation and Migration and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma Patients

  2014cited by this paper
• Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner

  2014cited by this paper
• A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection.

  2013cited by this paper
• Cancer metabolism, stemness and tumor recurrence

  2013cited by this paper
• Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer

  2013cited by this paper
• SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.

  2013cited by this paper
• Recent agents targeting HIF‐1α for cancer therapy

  2013cited by this paper
• Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor.

  2013cited by this paper
• Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma

  2012cited by this paper
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

  2012cited by this paper
• Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.

  2012cited by this paper
• Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors

  2011cited by this paper
• Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.

  2011cited by this paper
• EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

  2008cited by this paper
• Tumor cell metabolism: cancer's Achilles' heel.

  2008cited by this paper
• Regulation of tumor pH and the role of carbonic anhydrase 9

  2007cited by this paper
• Inhibitory effect of tumor cell-derived lactic acid on human T cells.

  2007cited by this paper
• AKT/PKB signaling: navigating downstream.

  2007cited by this paper
• The Plasma Membrane Lactate Transporter MCT4, but Not MCT1, Is Up-regulated by Hypoxia through a HIF-1α-dependent Mechanism*

  2006cited by this paper
• Hypoxia signalling in cancer and approaches to enforce tumour regression

  2006cited by this paper
• Prospective validation of the Barcelona Clinic Liver Cancer staging system.

  2006cited by this paper
• Why do cancers have high aerobic glycolysis?

  2004cited by this paper
• Liver Resection for Hepatocellular Carcinoma on Cirrhosis: Univariate and Multivariate Analysis of Risk Factors for Intrahepatic Recurrence

  2003cited by this paper
• The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells.

  2000cited by this paper
• Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

  2000cited by this paper

• Research progress on the role of lactylation modification in the development of hepatocellular carcinoma

  2026cites this paper
• Cannabidiol–Ion Channel Interactions Represent a Promising Preventive and Therapeutic Strategy in Hepatocellular Carcinoma

  2026cites this paper
• HIF-1α stabilization in osteoclasts induces the expression of aerobic glycolysis-related proteins GLUT1, LDHA, and MCT4.

  2025cites this paper
• Noninvasive prognostication of hepatocellular carcinoma based on cell-free DNA methylation

  2025cites this paper
• MCT4: a key player influencing gastric cancer metastasis and participating in the regulation of the metastatic immune microenvironment

  2025cites this paper
• Association between the Expression of Monocarboxylate Transporters in Tumors and Surrounding Stromal Cells and Cancer Prognosis: A Meta-Analysis.

  2025cites this paper
• Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma

  2025cites this paper
• Role of lactate and lactate metabolism in liver diseases (Review)

  2024cites this paper
• Metabolic Crossroad Between Macrophages and Cancer Cells: Overview of Hepatocellular Carcinoma

  2024cites this paper
• Altered Metabolites in Hepatocellular Carcinoma (HCC) Paving the Road for Metabolomics Signature and Biomarkers for Early Diagnosis of HCC

  2024cites this paper
• Knockdown of SLC16A3 decreases extracellular lactate concentration in hepatocellular carcinoma, alleviates hypoxia and induces ferroptosis.

  2024cites this paper
• MCT4 is an independent prognostic factor and affects immune cell infiltration in patients with colorectal liver oligometastases

  2024cites this paper
• Exploring monocarboxylate transporter inhibition for cancer treatment

  2024cites this paper
• Metabolic reprogramming and its clinical implication for liver cancer

  2023cites this paper
• Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis

  2023cites this paper
• Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma

  2023cites this paper
• Characteristics of lactate metabolism phenotype in hepatocellular carcinoma

  2023cites this paper
• A systemic analysis of monocarboxylate transporters in ovarian cancer and possible therapeutic interventions

  2023cites this paper
• Monocarboxylate transporter 4 promotes the migration of non‑cancerous L929 fibroblast cells by activating the IGF1/IGF1R/PIK3R3/SGK1 axis

  2023cites this paper
• Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy

  2023cites this paper
• Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma

  2023cites this paper
• Metabolic heterogeneity protects metastatic mucosal melanomas cells from ferroptosis

  2022cites this paper
• Identification and Validation of a Prognostic Model Based on Three MVI-Related Genes in Hepatocellular Carcinoma

  2022cites this paper
• Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

  2022cites this paper
• MCT4 Promotes Hepatocellular Carcinoma Progression by Upregulating TRAPPC5 Gene

  2022influential citation
• Differential response of hepatocellular carcinoma glycolytic metabolism and oxidative stress markers after exposure to human amniotic membrane proteins

  2022cites this paper
• Heat shock protein A12A activates migration of hepatocellular carcinoma cells in a monocarboxylate transporter 4–dependent manner

  2022cites this paper
• Useful genes for predicting the efficacy of transarterial chemoembolization in hepatocellular carcinoma

  2022cites this paper
• Mechanobiological Implications of Cancer Progression in Space

  2021cites this paper
• High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer

  2021cites this paper
• MCT4 is induced by metastasis-enhancing pathogenic mitochondrial NADH dehydrogenase gene mutations and can be a therapeutic target

  2021cites this paper
• MCT1 expression is independently related to shorter cancer-specific survival in clear cell renal cell carcinoma.

  2021cites this paper
• The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential

  2021cites this paper
• Differential Response of Human Amniotic Membrane Proteins in Hepatocellular Carcinoma: Analysis of the Glycolytic Metabolism

  2021cites this paper
• Nanotherapeutics for immune network modulation in tumor microenvironments.

  2021cites this paper
• Human monocarboxylate transporter 1, 4 (hMCT1, 4) の基質選択性の違いを決定する分子メカニズムに関する研究

  2020cites this paper
• Clinicopathological and prognostic involvements of MCT1, MCT4 and IL-7R in esophageal squamous cell carcinoma CURRENT STATUS: POSTED

  2020cites this paper
• Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy

  2020cites this paper
• The fuel and engine: The roles of reprogrammed metabolism in metastasis of primary liver cancer

  2020influential citation
• Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics

  2020cites this paper
• Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference

  2020cites this paper
• How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

  2020cites this paper
• NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling

  2020cites this paper
• MCT4 has a potential to be used as a prognostic biomarker - a systematic review and meta-analysis

  2019cites this paper
• Clinicopathological and prognostic involvements of MCT1, MCT4 and IL7R in esophageal squamous cell carcinoma

  2019cites this paper
• Structural insights on druggable hotspots in CD147: A bull's eye view.

  2019cites this paper
• Intratumoral reciprocal expression of monocarboxylate transporter 4 and glypican-3 in hepatocellular carcinomas

  2019cites this paper
• KIFC1 promotes the proliferation of hepatocellular carcinoma in vitro and in vivo

  2019cites this paper
• Prognostic value of monocarboxylate transporter 4 in patients with esophageal squamous cell carcinoma.

  2018cites this paper
• Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy

  2018cites this paper
• Downregulation of mir-542-3p promotes cancer metastasis through activating TgF- β /smad signaling in hepatocellular carcinoma

  2018cites this paper
• Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities

  2018cites this paper
• Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy

  2018cites this paper
• Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.

  2018cites this paper
• Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma

  2018cites this paper
• The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors

  2018cites this paper
• Downregulation of miR-542-3p promotes cancer metastasis through activating TGF-β/Smad signaling in hepatocellular carcinoma

  2018cites this paper
• Enhanced glycolysis, regulated by HIF-1&agr; via MCT-4, promotes inflammation in arsenite-induced carcinogenesis

  2017cites this paper
• Targeting MCT4 for treatment of advanced prostate cancers : inhibiting cell proliferation and enhancing anticancer immunity through suppressing lactic acid secretion and elevated glycolysis

  2017cites this paper
• Interplay between Tumor Microenvironment and Cancer Cells

  2016cites this paper
• Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects

  2016cites this paper
• Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?

  2016cites this paper
• MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis

  2016cites this paper
• Einfluss des Transkriptionsfaktors Nuclear factor E2-related factor 2 (Nrf2) auf die Metabolische Reprogrammierung kolorektaler Zellen während der entzündlichen Karzinogenese des Darmes

  2015cites this paper
• Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis

  2015cites this paper
• Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma.

  2015cites this paper